Albert M Kim
5PUBLICATIONS
13CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Dec 14, 2022
A phase 2a, randomized, double-blind, placebo-controlled, three-arm, parallel-group study to assess the efficacy, safety, tolerability and pharmacodynamics of PF-06835919 in patients with non-alcoholic fatty liver disease and type 2 diabetes.Aditi R Saxena, Stephanie-An Lyle, Kaivan Khavandi
|Oct 12, 2021
ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials.Roberto A Calle, Neeta B Amin, Santos Carvajal-Gonzalez
|Jun 15, 2021
Danuglipron (PF-06882961) in type 2 diabetes: a randomized, placebo-controlled, multiple ascending-dose phase 1 trial.Aditi R Saxena, Donal N Gorman, Ryan M Esquejo
|Nov 29, 2019
Targeting diacylglycerol acyltransferase 2 for the treatment of nonalcoholic steatohepatitis.Neeta B Amin, Santos Carvajal-Gonzalez, Julie Purkal
|Jan 10, 2019
Pharmacokinetics, pharmacodynamics, and safety of bococizumab, a monoclonal antibody against proprotein convertase subtilisin/kexin type 9, in healthy subjects when administered in co-mixture with recombinant human hyaluronidase: A phase 1 randomized trial.Almasa Bass, Anna Plotka, Khurshid Mridha
Pageof 1
Frequent Collaborators
2 joint publications
Aditi R Saxena
2 joint publications
William P Esler
1 joint publications
Neeta B Amin
1 joint publications
Santos Carvajal-Gonzalez
1 joint publications
Julie Purkal
1 joint publications
Tong Zhu
1 joint publications
Kristin Chidsey
1 joint publications
Bryan Goodwin
1 joint publications
Donal N Gorman
1 joint publications
David A Griffith
